Evidence map›Paper›PMID 41343441›Full record

ArticlePloS one2025

Temporal shifts in prognostic factors for 90- and 180-day outcomes after stroke thrombolysis: A machine learning analysis.

Aixia Chen, Ao Li, Youli Jiang, Huan Ye

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aixia ChenDepartment of Neurology, People's Hospital of Longhua, Shenzhen, China.
Ao LiClinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, China.
Youli JiangDepartment of Neurology, People's Hospital of Longhua, Shenzhen, China.ORCID https://orcid.org/0000-0002-6856-5177
Huan YeDepartment of Neurology, People's Hospital of Longhua, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrognostication at 90 and 180 days after thrombolysis for acute ischemic stroke (AIS) is critical, yet the temporal evolution of key predictors remains inadequately understood. The utility of machine learning for systematically comparing prognostic factors across these distinct time points remains to be fully established.

methodWe retrospectively analyzed consecutive AIS patients undergoing intravenous thrombolysis from October 2020 to December 2024. Features were selected from pre-therapy baseline data via univariable analysis and LASSO regression to develop five machine learning models. Model performance and clinical utility were assessed by AUC-ROC and Decision Curve Analysis (DCA), respectively. The primary endpoint was a modified Rankin Scale > 2 at 90 and 180 days.

resultsA total of 432 patients were included. At 90 days, 81 patients (18.8%) had an unfavorable outcome. By the 180-day follow-up, 86 patients (19.9%) were lost to follow-up. Among the remaining 346 patients, 48 (13.9%) had an unfavorable outcome. On the holdout test set, Logistic Regression (AUC = 0.757) and Random Forest (AUC = 0.833) were the optimal models for 90- and 180-day outcomes, respectively. While baseline NIHSS score and age were dominant predictors for both endpoints, a notable temporal shift in biomarker significance emerged: admission fibrinogen was a key predictor at 90 days, but was supplanted by white blood cell count for the 180-day prognosis.

conclusionOur study reveals a crucial temporal evolution in prognostic biomarkers after thrombolysis, shifting from fibrinogen at 90 days to white blood cell count at 180 days. This dynamic landscape of predictors, identified through machine learning, underscores the necessity of developing time-specific models to accurately forecast patient recovery.

Indexed as

Ischemic StrokeMachine LearningStrokeThrombolytic TherapyAgedAged, 80 and overFemaleFibrinolytic AgentsHumansMaleMiddle AgedPrognosisRetrospective StudiesTime FactorsTreatment OutcomeFibrinolytic Agents

Identifiers

PMID41343441
PMCPMC12677472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.